Net income of Corcept Therapeutics under GAAP for the 3 months of 2022 was $22.797 million, down 2.8% from $23.465 million in the previous year. Revenue increased 17.9% to $93.688 million compared to $79.437 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept